Differential signaling by CpG DNA in DCs and B cells: Not just TLR9

Trends in Immunology

Volumn 24, Issue 10, 2003, Pages 519-522

  Verthelyi, Daniela ^a   Zeuner, Rainald A ^b  

^a Ctr for Biologics Res Evaluation   (United States)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN; CHLOROQUINE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; RECEPTOR; TOLL LIKE RECEPTOR 9;

B LYMPHOCYTE; CELL ACTIVATION; CPG ISLAND; DENDRITIC CELL; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; SOMATOSTATIN CELL;

EID: 0141559412     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00243-6     Document Type: Short Survey

References (25)

1. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Ann. Rev. Immunol. 20:2002;709-760.
2. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
3. Kadowaki N., et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:2001;863-869.
4. Takeshita F., et al. Role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167:2001;3555-3558.
5. Hornung V., et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168:2002;4531-4537.
6. Verthelyi D., et al. Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166:2001;2372-2377.
7. Bauer M., et al. DNA activates human immune cells through a CpG sequence-dependent manner. Immunology. 97:1999;699-705.
8. Hartmann G., Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164:2000;944-952.
9. Verthelyi D., et al. CpG oligodeoxynucleotides as vaccine adjuvants in primates. J. Immunol. 168:2002;1659-1663.
10. Krug A., et al. Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur. J. Immunol. 31:2001;2154-2163.
11. Kerkmann M., et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170:2003;4465-4474.
12. Krug A., et al. Identification of CpG oligonucleotide sequences with high induction of IFNα/β in plasmacytoid dendritic cells. Eur. J. Immunol. 31:2001;2154-2163.
13. Hemmi H., et al. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170:2003;3059-3064.
14. Gursel M., et al. CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells. Eur. J. Immunol. 32:2002;2617-2622.
15. Gursel M., et al. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J. Leukoc. Biol. 71:2002;813-820.
16. Ahmad-Nejad P., et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:2002;1958-1968.
17. Ishii K.J., et al. Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196:2002;269-274.
18. Barton G.M., Medzhitov R. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270:2002;81-92.
19. Underhill D.M. Toll-like receptors: networking for success. Eur. J. Immunol. 33:2003;1767-1775.
20. Hemmi H., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:2002;196-200.
21. Lee S.W., et al. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials. J. Immunol. 165:2000;3631-3639.
22. O'Neill L.A., et al. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24:2003;286-289.
23. Takauji R., et al. CpG-DNA-induced IFN-α production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J. Leukoc. Biol. 72:2002;1011-1019.
24. Hartmann G., et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33:2003;1633-1641.
25. Marshall J.D., et al. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 73:2003;781-792.